General - Press Releases

Date	Title	Company
19-Jul-2023	Kovrr Appoints Two Cybersecurity & Risk Experts to CISO Advisory Board to Support Rapid Global Customer Growth	Businesswire
19-Jul-2023	Koch Modular Celebrates Launch of “Project Enterprise” Carbon Capture System	Businesswire
19-Jul-2023	Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing	Businesswire
19-Jul-2023	Macnica and Dragos to Deliver OT Cybersecurity to Critical Infrastructure and Manufacturing Control Systems in Japan	Businesswire
19-Jul-2023	Wilson Bryan, M.D., Former Director of FDA CBER’s Office of Tissues and Advanced Therapies, Joins Greenleaf	Businesswire
19-Jul-2023	KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million	Businesswire
19-Jul-2023	Evolus to Report Second Quarter 2023 Results and Provide Business Update	Businesswire
19-Jul-2023	Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023	Businesswire
19-Jul-2023	Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities	Businesswire
19-Jul-2023	MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction	Businesswire
19-Jul-2023	Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call	Businesswire
19-Jul-2023	FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis	Businesswire
19-Jul-2023	Global Permanent Magnets Market Analysis 2023-2030 - Rising Demand in Medical Devices and Smart Electronics Drives Growth - ResearchAndMarkets.com	Businesswire
19-Jul-2023	Aviceda Announces Podium Presentations on AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of Geographic Atrophy from Macular Degeneration, at American Society of Retina Specialists (ASRS) and the OIS Retina Innovation Summit Meetings	Businesswire
19-Jul-2023	Riparian Pharmaceuticals Announces Agreements with Pfizer for Novel Cardiovascular Programs	Businesswire
19-Jul-2023	Coya Therapeutics (“Coya”) Announces the Appointment of Dr. Merit Cudkowicz, M.D., M.Sc., as Clinical Advisor to Support the Development of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)	Businesswire
19-Jul-2023	GlycoMimetics to Report Second Quarter 2023 Financial Results on August 2, 2023	Businesswire
19-Jul-2023	Harrow Prices $60 Million Public Offering of Common Stock	Businesswire
19-Jul-2023	Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer	Businesswire
19-Jul-2023	Growing Demand for Algae Protein and Omega-3 Fatty Acids Drives Europe Microalgae Market to Reach $491.9 Million by 2030 - ResearchAndMarkets.com	Businesswire